Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT06276868RecruitingBreast Cancer | HER2-positive Breast Cancer
-
NCT05590559RecruitingBreast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction
-
NCT05433753Recruiting
-
NCT05190094RecruitingHormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
-
NCT05159323RecruitingBreast Carcinoma; Magnetic Resonance Imaging; Diffusion Spectrum Imaging
-
NCT03906669RecruitingHormone Receptor Positive Tumor | Early-stage Breast Cancer
-
NCT03730922RecruitingBreast Neoplasm Female | Breast Implant; Complications | Complication of Radiation Therapy
-
NCT05375461CompletedHR-positive,HER2-negative in Advanced Breast Cancer
-
NCT05538000Active, not recruitingNo Metastatic Breast Cancer
-
NCT03953833CompletedHER2-positive Breast Cancer
-
NCT05975437Enrolling by invitationBreast Cancer | Breast Cancer Female | Survivorship
-
-
NCT01124695CompletedBreast Cancer | Stage IV Breast Cancer
-
NCT02692755CompletedHormone Receptor Positive HER-2 Negative Breast Cancer
-
NCT02592083Active, not recruitingEarly-Stage Breast Carcinoma | Hormone Receptor Positive Tumor
-
NCT02441946CompletedBreast Cancer | Early-Stage Breast Carcinoma | Hormone Receptor Positive Tumor
-
NCT04175821CompletedLate Effects of Hypofractionated Radiotherapy in Breast Cancer
-
NCT02149524CompletedHER2 Positive Early or Locally Advanced Breast Cancer
-
NCT01176838TerminatedNewly Diagnosed Breast Cancer
-
NCT01503905UnknownBreast Cancer Nos Premenopausal
-
NCT02057029CompletedBreast Cancer | Early Stage Estrogen Receptor (ER) Positive Breast Cancer
-
NCT04504916TerminatedGastric Cancer | Pancreatic Cancer | NSCLC | Platinum-resistant Ovarian Cancer | Triple-negative Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Non-squamous Non-small-cell Lung Cancer | Estrogen-receptor-positive Breast Cancer | Progesterone-receptor-positive Breast Cancer
-
-
NCT07624617Not yet recruitingMetastatic Breast Cancer
-
NCT07528638Not yet recruiting
-
NCT07397585Recruiting
-
NCT07378319RecruitingBreast Cancer Females
-
NCT07294508Recruiting
-
NCT07238894Recruiting
-
NCT07180914Not yet recruiting
-
NCT07292571Enrolling by invitation
-
NCT07221071CompletedBreast Cancer | Mindfulness
-
-
NCT07054723RecruitingBreast Cancer | Stress | Cognitive Dysfunction | Cognitive Change | Breast Neoplasm | Breast Carcinoma
-
NCT04291950WithdrawnTriple Negative Breast Cancer
-
NCT07560553Not yet recruitingPregnancy Related | Breast Feeding, Exclusive
-
NCT07370051Not yet recruitingBreastfeeding | Midwifery | Breast | Newborn Infant
-
NCT07358182RecruitingHER2-positive Breast Cancer | HER2-low Breast Cancer | Trastuzumab-rezetecan
-
NCT07599137Not yet recruitingHR+/HER2- Breast Cancer
-
NCT07483996Not yet recruitingEarly-Stage Breast Cancer
-
NCT07464457Recruiting
-
NCT07399808Recruiting
-
NCT07215364Not yet recruiting
-
NCT07166042RecruitingBreast Cancer | Gynecologic Cancer
-
NCT07133685Not yet recruitingBreast Cancer
-
NCT07120087Recruiting
-
NCT07100106Recruiting
-
NCT07093931Not yet recruiting
-
NCT07076147Recruiting
-
NCT07067307Not yet recruiting
-
NCT07040891Recruiting